NCT03745560 Intraoperative EABR for Decision Making
| NCT ID | NCT03745560 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Christoph Arnoldner |
| Condition | Vestibular Schwannoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 15 participants |
| Start Date | 2017-05-23 |
| Primary Completion | 2026-05-23 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 15 participants in total. It began in 2017-05-23 with a primary completion date of 2026-05-23.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this study patients undergoing simultaneous translabyrinthine vestibular schwannoma resection and cochlear implantation are included. The goal of the study is to correlate the eABR results with postoperative hearing results.
Eligibility Criteria
Inclusion Criteria: * Patients between 18 and 99 years undergoing translabyrinthine vestibular schwannoma resection * Patients wanted hearing rehabilitation with a cochlear implant Exclusion Criteria: * patients who do not want to be part of the study
Contact & Investigator
Christoph Arnoldner, MD
PRINCIPAL INVESTIGATOR
MUW, Allgemeines Krankenhaus
Frequently Asked Questions
Who can join the NCT03745560 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Vestibular Schwannoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03745560 currently recruiting?
Yes, NCT03745560 is actively recruiting participants. Contact the research team at valerie.dahm@meduniwien.ac.at for enrollment information.
Where is the NCT03745560 trial being conducted?
This trial is being conducted at Vienna, Austria.
Who is sponsoring the NCT03745560 clinical trial?
NCT03745560 is sponsored by Christoph Arnoldner. The principal investigator is Christoph Arnoldner, MD at MUW, Allgemeines Krankenhaus. The trial plans to enroll 15 participants.